Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Doximity Raises FY2026 Sales Guidance from $628.000M-$636.000M to $640.000M-$646.000M vs $635.022M Est

Author: Benzinga Newsdesk | November 06, 2025 04:03pm
Doximity (NYSE:DOCS) raises FY2026 sales outlook from $628.000 million-$636.000 million to $640.000 million-$646.000 million vs $635.022 million estimate.

Posted In: DOCS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist